13D/13G Filings - Atlas Venture Fund X, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
5:28 pm
Purchase
2020-12-3113GGeneration Bio Co.
GBIO
Atlas Venture Fund X, L.P. 1,011,194
21.700%
1,011,194increase
(New Position)
Filing
History
2021-02-16
5:27 pm
Purchase
2020-12-3113GKymera Therapeutics, Inc.
KYMR
Atlas Venture Fund X, L.P. 7,948,982
17.900%
7,948,982increase
(New Position)
Filing
History
2021-02-16
5:25 pm
Purchase
2021-02-0513DGemini Therapeutics, Inc.
GMTX
Atlas Venture Fund X, L.P. 401,505
8.900%
401,505increase
(New Position)
Filing
History
Goto Prev, 0, 1